PACIFY LAUNCHES NEW, BEST-IN-CLASS MATERNAL HEALTH PLATFORM
Centered on personalizing the patient experience for expecting and new parents, Pacify is revolutionizing virtual care to drive better outcomes...
Pregnancy
VIVUS Unveils Global Initiative to Advance Healthy and Sustainable Weight Management
VIVUS reaffirms commitment to combatting global obesity crisis on World Obesity Day 2025 with VIVUS For Life CAMPBELL, Calif., March...
Protega Pharmaceuticals collaborates with Wellgistics Health to support pharmacist education and increase patient access to the first and only FDA-approved abuse-deterrent immediate-release opioid, ROXYBOND™
ROXYBOND, formulated with patented, first-of-its-kind abuse-deterrent technology SentryBond™, is designed to provide multiple levels of protection PRINCETON, N.J., March 3, 2025...
Zevra Launches New Disease State Awareness Campaign, ‘Learn NPC, Read Between the Signs,’ to Drive Early Recognition and Treatment of Niemann-Pick Disease Type C
New website launched in honor of Rare Disease Day, Feb. 28, 2025 Awareness campaign includes educational resources and testing information...
Apellis Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results
Reported $781.4 million in full year 2024 revenues, representing 97% year-over-year growth SYFOVRE® (pegcetacoplan injection) full year 2024 net product...
Stork Club Launches the World’s First Comprehensive Care for Postpartum Depression to Help Employers Support Working Mothers
The solution features clinically proven digital diagnostics and therapy, delivering up to 20% immediate PPD symptom relief and 30-40% improvement...
Intra-Cellular Therapies Reports Fourth Quarter and Full-Year 2024 Financial Results
Fourth quarter 2024 CAPLYTA net product sales grew to $199.2 million, representing a 51% increase over the same period in...
Creative Medical Technology Holdings Applauds Presidential Initiative to Expand IVF Access, Showcasing OvaStem® Program’s Success and Growth Potential
OvaStem® Demonstrates Strong Long-Term Efficacy with No Safety Concerns, Backed by Pending Orphan Drug Designation for AlloStem®PHOENIX, Feb. 20, 2025...
Tech-Powered, Expert-Led, and Ready to Scale – SteelSky Ventures Invests in Posterity Health to Transform Fertility Care
ATLANTA, Feb. 19, 2025 /PRNewswire/ -- SteelSky Ventures, the world's leading women's health fund, has made a strategic investment in...
Arkstone Expands Maternal Care with NeoSure™: Now Integrating Breastfeeding Safety into OneChoice Reports
BOCA RATON, Fla., Feb. 13, 2025 /PRNewswire/ -- Arkstone, the leader in laboratory infectious disease guidance and antimicrobial stewardship, proudly...
BioCryst Launches ORLADEYO® (berotralstat) in Portugal
RESEARCH TRIANGLE PARK, N.C., Feb. 12, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that Infarmed in Portugal...
Orchard Therapeutics Appoints Robin Kenselaar to Chief Commercial Officer and Announces Multiple Business Updates Pertaining to its Approved HSC Gene Therapy for MLD
First U.S. patients being treated with Lenmeldy™ (atidarsagene autotemcel) in a commercial setting; other launch efforts progressing well following Food...
UPDATE: SpringWorks Therapeutics Announces FDA Approval of GOMEKLI™ (mirdametinib) for the Treatment of Adult and Pediatric Patients with NF1-PN
GOMEKLI™ (mirdametinib) capsules and tablets for oral suspension GOMEKLI™ (mirdametinib) capsules and tablets for oral suspension Saqib Islam, SpringWorks Therapeutics...
SpringWorks Therapeutics Announces FDA Approval of GOMEKLI™ (mirdametinib) for the Treatment of Adult and Pediatric Patients with NF1-PN
GOMEKLI™ (mirdametinib) capsules and tablets for oral suspension GOMEKLI™ (mirdametinib) capsules and tablets for oral suspension Saqib Islam, SpringWorks Therapeutics...
Femasys Announces UK Regulatory Approvals for FemaSeed® for Female Infertility Treatment and Two Diagnostic Devices
UK regulatory approval follows FemaSeed, FemVue and FemCerv clearance/ approvals in the U.S., Europe, Canada and IsraelATLANTA, Feb. 11, 2025...
BioCryst to Present New ORLADEYO® (berotralstat) Results from APeX-P Pediatric Trial at 2025 American Academy of Allergy, Asthma & Immunology / World Allergy Organization Joint Congress
RESEARCH TRIANGLE PARK, N.C., Feb. 10, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will...
KFSHRC Detects 276 Fetal Genetic Disorders Through Prenatal Care Saving SAR 360 Million Annually
RIYADH, Saudi Arabia, Feb. 10, 2025 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) is enhancing prenatal...
Comma Raises $2M Seed Round to Bring Personalized Science to Reproductive Health
The Period Care Company Emerges from Stealth with Launch of Secure Period Tracking App NASHVILLE, Tenn., Feb. 5, 2025 /PRNewswire/...
New Survey from Aeroflow Urology Reveals Lack of Postpartum Incontinence Care Causes Lasting Health Problems for Mothers
Despite 85% of mothers experiencing frequent bladder leaks during postpartum, the survey found only 15% of mothers received resources and...
Rhythm Pharmaceuticals to Present at Oppenheimer Annual Healthcare Life Sciences Conference in February
BOSTON, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on transforming the...